Antiviral Chemotherapy 4 / Advances in Experimental Medicine and Biology Bd.394 (PDF)
New Directions for Clinical Application and Research
(Sprache: Englisch)
The three years since our last conference in San Francisco have again seen a dramatic expansion of the number of antivirals either licensed or in the late stages of clinical trials. d4T is now licensed for HIV infection, famciclovir and the oral pro-drug of...
sofort als Download lieferbar
eBook (pdf)
Fr. 236.00
inkl. MwSt.
- Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
Produktdetails
Produktinformationen zu „Antiviral Chemotherapy 4 / Advances in Experimental Medicine and Biology Bd.394 (PDF)“
The three years since our last conference in San Francisco have again seen a dramatic expansion of the number of antivirals either licensed or in the late stages of clinical trials. d4T is now licensed for HIV infection, famciclovir and the oral pro-drug of acyclovir, valacyclovir, are now licensed for VZV infections in some countries. Moreover. oral ganciclovir, cidofovir, and sorivudine are not far behind. Clinical trials with the second-site reverse transcriptase inhibitors and the protease inhibitors for HlV infection are proceeding rapidly and on a broad scale, and the preliminary results would suggest that several of these classes of drugs will be licensed as well. Despite this optimism, however, there is increasing evidence that antiviral-resistant strains of pathogenic viruses will be a significant problem, perhaps especially with therapy of HIV infection, and there remains a desperate need for improved drugs (with either improved efficacy or decreased toxicity, or both) for CMV and HIV infections. This book is the edited proceedings of the Fourth Triennial Conference on Antiviral Chemotherapy, held in San Francisco, in November 1994. The conference was sponsored by the University of California, San Francisco, and co-sponsored by the International Society for Antiviral Research (ISAR), the Macfarlane Burnet Centre for Medical Research in Melbourne, Australia, and the Australian National Centre for HIV Virology Research. The conference had been organized to present an overview of the field of antiviral chemotherapy.
Bibliographische Angaben
- 2013, 1996, 440 Seiten, Englisch
- Herausgegeben: John Mills, Paul A. Volberding, Lawrence Corey
- Verlag: Springer, New York
- ISBN-10: 1475792093
- ISBN-13: 9781475792096
- Erscheinungsdatum: 29.06.2013
Abhängig von Bildschirmgrösse und eingestellter Schriftgrösse kann die Seitenzahl auf Ihrem Lesegerät variieren.
eBook Informationen
- Dateiformat: PDF
- Grösse: 50 MB
- Mit Kopierschutz
- Vorlesefunktion
Sprache:
Englisch
Kopierschutz
Dieses eBook können Sie uneingeschränkt auf allen Geräten der tolino Familie lesen. Zum Lesen auf sonstigen eReadern und am PC benötigen Sie eine Adobe ID.
Kommentar zu "Antiviral Chemotherapy 4 / Advances in Experimental Medicine and Biology Bd.394"
0 Gebrauchte Artikel zu „Antiviral Chemotherapy 4 / Advances in Experimental Medicine and Biology Bd.394“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Antiviral Chemotherapy 4 / Advances in Experimental Medicine and Biology Bd.394".
Kommentar verfassen